Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Cannabidiol Market Expected To Reach $32.5 Billion By 2030 At 62.61% CAGR
The cannabidiol market has experienced significant expansion in recent years. It is projected to increase from $15.44 billion in 2025 to $20.34 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 31.7%. This historical progression can be linked to factors such as the legalization of medical cannabis in key regions, an increase in alternative medicine adoption, growing consumer awareness of CBD benefits, the broadening of hemp cultivation, and the accessibility of CBD extraction technologies.
The cannabidiol market is anticipated to experience substantial growth in the years ahead. It is expected to achieve a valuation of $62.61 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 32.5%. This projected expansion during the forecast period is fueled by elements such as the increasing acceptance of CBD within healthcare sectors, escalating investments in cannabinoid research, the proliferation of regulated CBD retail channels, a rising demand for plant-derived therapeutics, and greater standardization of CBD formulations. Significant trends for the forecast period include the expanding adoption of CBD-based therapeutic interventions, a growing demand for wellness and nutraceutical items, increased utilization in personal care formulations, the proliferation of pharmaceutical-grade CBD offerings, and an intensified focus on regulatory compliance.
Download A Free Sample Report For Comprehensive Market Insights:
#Cannabidiol Market Growth Factors: Which Forces Are Supporting Market Expansion?
The growing incidence of neurological disorders is anticipated to stimulate the expansion of the cannabidiol market in the future. A neurological disorder is a medical state affecting both the central and peripheral nervous systems, encompassing the brain, spinal cord, and the body’s nerves. Cannabis assists in managing these neurological conditions by regulating calcium homeostasis and diminishing neuroinflammation. For example, in March 2023, according to the Alzheimer’s Association, a US-based nonprofit voluntary health organization, approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia in 2023, a number expected to reach 13.8 million by 2060. This escalating prevalence of neurological disorders is thus propelling the growth of the cannabidiol market.
Cannabidiol Market Segments: Where Are The Largest Growth Opportunities?
The cannabidiol market covered in this report is segmented –
1) By Product: Oil, Tinctures, Suppository, Transdermal Patches, Vape Oil, Isolates, Creams and Roll-on, Capsules, Tablet, Other Products
2) By Source: Marijuana, Hemp
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores, Other Distribution Channels
4) By Application: Medical, Personal Use, Pharmaceuticals, Wellness
Subsegments:
1) By Oil: Full-Spectrum CBD Oil, Broad-Spectrum CBD Oil, CBD Isolate Oil
2) By Tinctures: CBD Tinctures with Flavoring, Unflavored CBD Tinctures
3) By Suppository: Rectal Suppositories, Vaginal Suppositories
4) By Transdermal Patches: CBD Patches for Pain Relief, CBD Patches for Sleep
5) By Vape Oil: CBD Vape Cartridges, CBD Vape Juice
6) By Isolates: CBD Powder, CBD Crystals
7) By Creams and Roll-on: Topical CBD Creams, CBD Roll-on Gels
8) By Capsules: Softgel Capsules, Hard Capsules
9) By Tablet: CBD Tablets, CBD Chewable Tablets
10) By Other Products: Gummies, Beverages, Edibles
Cannabidiol Market Industry Trends: What Changes Are Reshaping Demand?
Leading entities within the cannabidiol market are focusing on advanced product development, which includes the introduction of epilepsy treatments to improve seizure control. The release of an epilepsy therapeutic marks the formal debut or commercial availability of a medicinal product specifically formulated to prevent, manage, or cure epilepsy, with the goal of enhancing seizure handling and patient well-being. As an example, in January 2024, Akumentis Healthcare Ltd., a pharmaceutical manufacturing firm situated in India, unveiled Clasepi for addressing epilepsy. A novel DCGI-approved prescribed cannabidiol preparation has been launched in India to assist in controlling seizures linked to Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in individuals aged one year and above. This manufactured CBD item contains under 0.1% THC, thereby guaranteeing it is non-psychotropic. Clinical research demonstrates its efficacy in decreasing seizures, especially when conventional antiseizure drugs prove insufficient.
Cannabidiol Market Major Participants And Competitive Dynamics
Major companies operating in the cannabidiol market are Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte’s Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC
Access The Complete Cannabidiol Market Report:
Cannabidiol Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the cannabidiol market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.